Policy Comments
The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.
Group letter supporting the Consumer Financial Protection Bureau's (CFPB) proposed rule on medical debt reporting.
Group letter supporting the passage of the Cancer Drug Parity Act (HR 6301/S. 2039) and the inclusion of this policy in any reforms to the 21st Century Cures Act
Group letter re supporting the rule’s prohibiting of creditors using medical debt information and status form making credit determinations
Group letter endorsing the Radiation Oncology Case Rate Value-Based Payment Program Act of 2024 with the goal of moving towards a cancer care system that reimburses for quality and value of care rather than paying per treatment.
Group letter to CMS related to their recent guidance for implementing the Medicare Drug Negotiation Program. Comments focus on agency's process for engaging patients in its decisions, including determinations related to a treatment’s clinical effectiveness, unmet need and therapeutic alternatives, as well as the agency’s use of value assessments.
Group letter to CMS providing comments on the draft guidance of the Medicare Drug Price Negotiation Program (MDPNP) for 2027.
Group letter urging Secretaries Becerra, Su, and Yellen to ensure that any revision of the cost-sharing rule related to copay accumulator adjustment policies includes clear, commonsense protections guaranteeing that copayments made by or on behalf of an enrollee are counted as payments toward their annual cost-sharing contributions. The letter also request a meting on this topic at their earliest convenience.
Group letter commenting on the FY2025 Inpatient Prospective Payment System (IPPS) and Long Term Care Hospital (LTCH) Prospective Payment System Proposed Rules.
CSC letter supporting the Nancy Sewell Gardner Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 2407) and urging the passage of the amended bill out of the U.S. House Committee on Ways & Means.
Group letter to the DoL, DHHS, and DoT commenting on the new Notice of Benefit Payment Parameters (NBPP) and Alternative Funding Program (AFP) rules to provide the greatest protections possible to health insurance enrollees in large group and self-insured plans.